Kurt I. Kamrud

2.2k total citations
43 papers, 1.6k citations indexed

About

Kurt I. Kamrud is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Kurt I. Kamrud has authored 43 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 12 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Kurt I. Kamrud's work include Mosquito-borne diseases and control (11 papers), Viral Infections and Vectors (10 papers) and Viral gastroenteritis research and epidemiology (9 papers). Kurt I. Kamrud is often cited by papers focused on Mosquito-borne diseases and control (11 papers), Viral Infections and Vectors (10 papers) and Viral gastroenteritis research and epidemiology (9 papers). Kurt I. Kamrud collaborates with scholars based in United States, Sweden and Vietnam. Kurt I. Kamrud's co-authors include Jonathan O. Rayner, Sergey A. Dryga, D. L. Harris, Jay W. Hooper, Connie S. Schmaljohn, Mark Mogler, Fredrik Elgh, Barry J. Beaty, Stephen Higgs and Ann M. Powers and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kurt I. Kamrud

41 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt I. Kamrud United States 26 763 454 407 377 284 43 1.6k
Craig Street United States 15 880 1.2× 712 1.6× 334 0.8× 197 0.5× 205 0.7× 17 2.0k
Mark D. Stenglein United States 27 1.3k 1.7× 781 1.7× 708 1.7× 437 1.2× 408 1.4× 79 2.8k
Juan García‐Arriaza Spain 25 811 1.1× 587 1.3× 626 1.5× 394 1.0× 413 1.5× 68 2.1k
Anthony C. Marriott United Kingdom 23 703 0.9× 237 0.5× 657 1.6× 179 0.5× 227 0.8× 49 1.4k
Masayuki Horie Japan 20 625 0.8× 323 0.7× 677 1.7× 174 0.5× 94 0.3× 72 1.5k
Jean-Christophe Audonnet France 24 754 1.0× 305 0.7× 1.1k 2.7× 270 0.7× 351 1.2× 37 2.0k
Peter J. Kerr Australia 27 579 0.8× 232 0.5× 603 1.5× 223 0.6× 202 0.7× 65 1.9k
L E Perryman United States 34 760 1.0× 363 0.8× 387 1.0× 117 0.3× 632 2.2× 69 2.7k
Philippa M. Beard United Kingdom 24 397 0.5× 542 1.2× 916 2.3× 119 0.3× 483 1.7× 58 2.0k
Robin Levis United States 17 932 1.2× 498 1.1× 493 1.2× 570 1.5× 213 0.8× 23 1.9k

Countries citing papers authored by Kurt I. Kamrud

Since Specialization
Citations

This map shows the geographic impact of Kurt I. Kamrud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt I. Kamrud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt I. Kamrud more than expected).

Fields of papers citing papers by Kurt I. Kamrud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt I. Kamrud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt I. Kamrud. The network helps show where Kurt I. Kamrud may publish in the future.

Co-authorship network of co-authors of Kurt I. Kamrud

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt I. Kamrud. A scholar is included among the top collaborators of Kurt I. Kamrud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt I. Kamrud. Kurt I. Kamrud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ngono, Annie Elong, José Ángel Regla-Nava, Darina Spasova, et al.. (2020). CD8 + T cells mediate protection against Zika virus induced by an NS3-based vaccine. Science Advances. 6(45). 29 indexed citations
2.
Kannan, Krishna, John Gill, Bolyn Hubby, et al.. (2017). Digital-to-biological converter for on-demand production of biologics. Nature Biotechnology. 35(7). 672–675. 56 indexed citations
3.
He, Wei, Angela C. Evans, Jia Geng, et al.. (2017). Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development. Journal of Biological Chemistry. 292(36). 15121–15132. 30 indexed citations
4.
Janke, Bruce H., et al.. (2013). Sequence-optimized and targeted double-stranded RNA as a therapeutic antiviral treatment against infectious myonecrosis virus in Litopenaeus vannamei. Diseases of Aquatic Organisms. 105(1). 57–64. 8 indexed citations
5.
Loynachan, Alan T., et al.. (2012). Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine. Vaccine. 30(11). 1944–1950. 59 indexed citations
6.
Sashihara, Junji, Yo Hoshino, Tammy Krogmann, et al.. (2011). Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge. PLoS Pathogens. 7(10). e1002308–e1002308. 42 indexed citations
7.
Kamrud, Kurt I., et al.. (2010). Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle. Journal of General Virology. 91(7). 1723–1727. 22 indexed citations
8.
Hooper, Jay W., Joseph W. Golden, Peter Silvera, et al.. (2009). Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine. 28(2). 494–511. 54 indexed citations
9.
Nishimoto, Kevin, Kehui Wang, Kurt I. Kamrud, et al.. (2007). Restricted and Selective Tropism of a Venezuelan Equine Encephalitis Virus-Derived Replicon Vector for Human Dendritic Cells. Viral Immunology. 20(1). 88–104. 30 indexed citations
10.
Reap, Elizabeth A., et al.. (2007). Evaluation of the immunogenicity of an alphavirus replicon particle vaccine expressing the SARS-CoV spike (S) glycoprotein in non-human primates (B191). The Journal of Immunology. 178(1_Supplement). LB40–LB40. 1 indexed citations
11.
Haynes, Lia M., Congrong Miao, Jennifer L. Harcourt, et al.. (2007). Recombinant Protein-Based Assays for Detection of Antibodies to Severe Acute Respiratory Syndrome Coronavirus Spike and Nucleocapsid Proteins. Clinical and Vaccine Immunology. 14(3). 331–333. 16 indexed citations
12.
Hubby, Bolyn, Todd Talarico, Maureen F. Maughan, et al.. (2007). Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine. 25(48). 8180–8189. 59 indexed citations
13.
Kamrud, Kurt I., et al.. (2006). Alphavirus replicon approach to promoterless analysis of IRES elements. Virology. 360(2). 376–387. 41 indexed citations
14.
Nishimoto, Kevin, et al.. (2004). A Matter of Life and Death: VEE-Derived Replicon Particle Interactions with the Human Immune System. Journal of Immunotherapy. 27(6). S25–S25. 1 indexed citations
15.
Nelson, Edward L., DaRue A. Prieto, Peter Pushko, et al.. (2003). Venezuelan Equine Encephalitis Replicon Immunization Overcomes Intrinsic Tolerance and Elicits Effective Anti-tumor Immunity to the ‘Self’ tumor-associated antigen, neu in a Rat Mammary Tumor Model. Breast Cancer Research and Treatment. 82(3). 169–183. 31 indexed citations
16.
Rayner, Jonathan O., Sergey A. Dryga, & Kurt I. Kamrud. (2002). Alphavirus vectors and vaccination. Reviews in Medical Virology. 12(5). 279–296. 146 indexed citations
17.
Hooper, Jay W., Kurt I. Kamrud, Fredrik Elgh, David Custer, & Connie S. Schmaljohn. (1999). DNA Vaccination with Hantavirus M Segment Elicits Neutralizing Antibodies and Protects against Seoul Virus Infection. Virology. 255(2). 269–278. 112 indexed citations
18.
Ma, Meihui, et al.. (1999). Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism. Virus Research. 64(1). 23–32. 22 indexed citations
19.
Kamrud, Kurt I., Jay W. Hooper, Fredrik Elgh, & Connie S. Schmaljohn. (1999). Comparison of the Protective Efficacy of Naked DNA, DNA-based Sindbis Replicon, and Packaged Sindbis Replicon Vectors Expressing Hantavirus Structural Genes in Hamsters. Virology. 263(1). 209–219. 70 indexed citations
20.
Kamrud, Kurt I., Ken E. Olson, Stephen Higgs, J. O. Carlson, & Barry J. Beaty. (1998). Use of the Sindbis replicon system for expression of LaCrosse virus envelope proteins in mosquito cells. Archives of Virology. 143(7). 1365–1377. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig Street Breakdown of academic impact, for papers by Mark D. Stenglein Breakdown of academic impact, for papers by Juan García‐Arriaza Breakdown of academic impact, for papers by Anthony C. Marriott Breakdown of academic impact, for papers by Masayuki Horie Breakdown of academic impact, for papers by Jean-Christophe Audonnet Breakdown of academic impact, for papers by Peter J. Kerr Breakdown of academic impact, for papers by L E Perryman Breakdown of academic impact, for papers by Philippa M. Beard Breakdown of academic impact, for papers by Robin Levis
Rankless by CCL
2026